Share this on Twitter Share this on Facebook Share this on LinkedIn Share this on Sina Weibo Share this on Wechat Share this on LinkedIn A man walks by a sign for the Cominarty mRNA vaccine, and the Sinovac vaccine, at a Covid-19 vaccination clinic inside an MTR Station in Hong Kong, January 2, 2023. Credit: Vernon Yuen via AP Images After three years of COVID isolation, mainland Chinese residents are finally able to go abroad without having to quarantine when they get home. Many are using their first stops outside mainland borders to get injected with vaccines long available in much of the outside world. Clinics in Hong Kong, which opened its borders for quarantine-free travel on Jan. 8, say they are at full capacity serving mainland tourists with mRNA booster shots produced by Germany’s BioNTech. The Hong Kong branch of China Citic Bank International, a Chinese state-owned bank, is even offering free mRNA COVID jabs for mainland Chinese customers if they deposit enough funds in the bank. In Macau, where mRNA boosters are also available, Chinese tourists have overwhelmed local hospitals and private clinics with vaccine appointments. The rush for jabs is a direct result of mainland China remaining the world’s only major economy yet to approve mRNA vaccines, even though they offer better and longer lastingSubscribe or login to read the rest. Subscribers get full access to: Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else. A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times. A daily roundup of China finance, business and economics headlines. We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.